Letters to Officials
CCAGW Joins Coalition Supporting Reforms to the Sugar Program
The modest reforms included in the House farm bill are a meaningful first step to reforming the sugar program.
CCAGW Urges Senate Judiciary Committee to Support IP Rights in Pharmaceutical Drug Industry
Weakening IP rights will hinder the future research and development needed to create new cures and technologies.
CCAGW Leads Coalition Supporting H.R. 8051, the Earmark Elimination Act
H.R. 8051 would create a permanent ban on earmarks in the House of Representatives.
CCAGW Urges Senate Homeland Security and Government Affairs Committee to Support S. 2871
S. 2871 would make federal agencies more secure and efficient while reducing costs and duplication.
CCAGW Urges House Oversight Committee to Support H.R. 262
The ALERT Act would bring more accountability and transparency to the regulatory process.
CAGW Joins Coalition Opposing Cuts to Medicare Advantage Program
Medicare Advantage is provided through private plans rather than government-run plans and allows private companies to compete.
CAGW Joins Coalition Opposing Cuts to Medicare Advantage Program
Medicare Advantage is provided through private plans rather than government-run plans and allows private companies to compete.
CCAGW Urges House Oversight Committee to Oppose H.R. 6283
H.R. 6283 would impose unnecessary and harmful regulations on PBMs that will lead to higher prices and fewer options.
CCAGW Urges House Oversight Committee to Support H.R. 262
The ALERT Act would bring more accountability and transparency to the regulatory process.
CCAGW Urges Florida Legislators to Oppose House Bill 1431
This legislation threatens drug innovation and development in the U.S. and will lead to fewer future cures.
CCAGW Urges West Virginia Legislators to Oppose Senate Bill 325
SB 325 would make changes to the federal 340B drug discount program.
CCAGW Joins Coalition Supporting H.R. 5779, The Fiscal Commission Act of 2023
A fiscal commission would take steps to put the nation back on the right fiscal track.
